Feedback
Menu

Home / Search / Record

eDNAtec Inc

COVID-19 Response: DeepSeq technology for monitoring SARS-CoV-2 and other emerging pathogens in environmental settings

A flag is a question, not a finding. It is not evidence that anything wrong happened.

CAD 62,644.00

Reported federal agreement value. An agreement can cover several years; this is not the amount paid out.

Selected because the publisher reports recipient province NL; NL Ledger has not established the work, benefit or jurisdiction from this record; source fields are available below.

This is the whole reported commitment or notice value, not the amount paid or an NL allocation.

Recipient
eDNAtec Inc
Agreement start
Sept. 27, 2020
Program
Industrial Research Assistance Program – Contributions to Firms
Record type
Federal grant or contribution

Receipt

agreement 172-2020-2021-Q3-957543, amendment 4

Open the source

Source location evidence

Location review incomplete.

Reported address: country: CA; province: NL; city: St. John's|St. John's; postal code: A1A 0R6.

How counted: latest of 4 rows (department reports running totals). Start: 2020-09-27; end: 2022-03-31; reported: not stated. Amount: published value.

    Full source fields
    _id
    35914584
    ref_number
    172-2020-2021-Q3-957543
    amendment_number
    4
    amendment_date
    2021-12-21
    agreement_type
    C
    recipient_type
    F
    recipient_business_number
    840885594
    recipient_legal_name
    eDNAtec Inc
    recipient_operating_name
    eDNAtec Inc
    research_organization_name
    recipient_country
    CA
    recipient_province
    NL
    recipient_city
    St. John's|St. John's
    recipient_postal_code
    A1A 0R6
    federal_riding_name_en
    St. John's East
    federal_riding_name_fr
    St. John's-Est
    federal_riding_number
    10006
    prog_name_en
    Industrial Research Assistance Program – Contributions to Firms
    prog_name_fr
    Programme d’aide à la recherche industrielle – Contributions aux entreprises
    prog_purpose_en
    The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
    prog_purpose_fr
    Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
    agreement_title_en
    COVID-19 Response: DeepSeq technology for monitoring SARS-CoV-2 and other emerging pathogens in environmental settings
    agreement_title_fr
    Réponse face à la COVID-19 : Technologie DeepSeq pour la surveillance du SRAS-CoV-2 et d'autres agents pathogènes émergents dans l'environnement
    agreement_number
    957543
    agreement_value
    62644
    foreign_currency_type
    foreign_currency_value
    agreement_start_date
    2020-09-27
    agreement_end_date
    2022-03-31
    coverage
    IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation. | Les projets des Contributions aux entreprises stimulent la création de richesse au Canada grâce à l’innovation technologique.
    description_en
    There is mounting evidence that a significant source of COVID-19 infections has been through the environment —particularly aerosolized droplets from infected peoples' lungs. A solution is proposed whereby genome sequencing technologies will be used to track pathogens indoors, where workers and/or consumers are in close proximity, using surface and air sampling technologies. This will support a tracking and early alert system for resurgence of the coronavirus or other pathogens (both viral and bacterial).
    description_fr
    Il est de plus en plus évident qu'une source importante d'infections par la COVID-19 est attribuable à l'environnement - en particulier les gouttelettes en aérosol provenant des poumons des personnes infectées. Une solution est proposée, selon laquelle des technologies de séquençage du génome seront utilisées pour suivre les agents pathogènes à l'intérieur, lorsque les travailleurs et les consommateurs sont à proximité, en utilisant des technologies d'échantillonnage de surface et d'air. Cette solution permettra de mettre en place un système de suivi et d'alerte rapide en cas de résurgence du coronavirus ou d'autres agents pathogènes (tant viraux que bactériens).
    naics_identifier
    541620
    expected_results_en
    The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
    expected_results_fr
    Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
    additional_information_en
    This agreement has been amended 1 time(s). The total amended value is -48,983 dollars.
    additional_information_fr
    Cet accord a été modifié 1 fois La valeur totale des modifications est de - 48 983 dollars.
    owner_org
    nrc-cnrc
    owner_org_title
    National Research Council Canada | Conseil national de recherches Canada

    Spot an error? Say so in the box below, or email corrections@nlledger.ca. What to send.

    Something missing, wrong or confusing?

    Say so here. No account is needed, and no email program. Every note is read.

    What people asked for, and what was done

    What kind of note is it? Optional

    The address of this page is sent with it, so there is no need to say where you were.

    Notes are read by the people who run the site. They are never shown on it. Privacy